Impact Of Splenomegaly On Mpn Symptoms And Association With Clinical Features : An Analysis By The Mpn Quality Of Life International Study Group
Holly L. Geyer(Mayo Clinic Hospital), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Zhenya Senyak, Lydia Roy(Centre Hospitalier Universitaire de Poitiers), Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), P. Zhang, Xiujuan Sun(Chinese Academy of Sciences), Heike L. Pahl(University Medical Center Freiburg), PA te Boekhorst, Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Jean‐Yves Cahn, Konstanze Doehner(University Hospital Ulm), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), F. Boyer, M. Grieshammer, Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Jessica Samuelsson(Karolinska Institutet), C. Besses(Hospital Del Mar), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Petter Johansson, Sonja Zweegman(Vrije Universiteit Amsterdam), R. Scherber, K. Bonatz(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), H. Schouten, F. Cervantes(Hospital Clínic de Barcelona), Jie Xu(Beijing Tongren Hospital), A Fuentes, Zhihua Xu(Ministry of Education of the People's Republic of China)
Haematologica
January 1, 2016
Cited by 1
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k